S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

XOMA XOMA Corporation

24.78

-0.66 (-2.59%)

May 03 2024 - Closed

Delayed by 15 minutes

FDA grants orphan drug status to XOMA's pancreatic cancer treatment NIS793

To read the full story on Seeking Alpha, click here.

XOMA (NASDAQ:XOMA)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more XOMA Charts.

XOMA (NASDAQ:XOMA)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more XOMA Charts.

XOMA Corporation News

XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
Tuesday 30 April 2024 (4 days ago) • GlobeNewswire Inc.

XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
Thursday 25 April 2024 (1 week ago) • GlobeNewswire Inc.

Actym Therapeutics Appoints Thomas Smart as CEO
Wednesday 24 April 2024 (1 week ago) • PR Newswire (US)

XOMA Corporation Announces Closing of Tender Offer
Wednesday 3 April 2024 (1 month ago) • GlobeNewswire Inc.

XOMA Declares Quarterly Preferred Stock Dividends
Thursday 21 March 2024 (1 month ago) • GlobeNewswire Inc.

XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.
Tuesday 19 March 2024 (2 months ago) • GlobeNewswire Inc.

XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
Friday 8 March 2024 (2 months ago) • GlobeNewswire Inc.

XOMA to Present at Upcoming Investor Conferences in March
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.

XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right
Friday 16 February 2024 (3 months ago) • GlobeNewswire Inc.

XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition
Thursday 18 January 2024 (4 months ago) • GlobeNewswire Inc.

Xoma to Make $1 Million Milestone Payment to LadRx After FDA Accepts Zevra Application for Arimoclomol
Thursday 11 January 2024 (4 months ago) • Dow Jones News

FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx
Thursday 11 January 2024 (4 months ago) • GlobeNewswire Inc.

More XOMA Corporation News Articles

Bell Buckle (PK)

Marketing Worldwide (PK)

Ubiquitech Software (PK)

Umbra Applied Technologies (PK)

Yuenglings Ice Cream (PK)

Alternet Systems (PK)

Auto Parts 4Less (PK)

AMC Entertainment

Moon Equity (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions